| scholarly article | Q13442814 |
| P50 | author | Ulrike Koehl | Q44365288 |
| Andrea Maisner | Q46153513 | ||
| Roberto Cattaneo | Q88591752 | ||
| P2093 | author name string | Manuel Grez | |
| Klaus Cichutek | |||
| Michael D Mühlebach | |||
| Christian J Buchholz | |||
| Andrea Maisner | |||
| Sabrina Funke | |||
| P2860 | cites work | Gene transfer in humans using a conditionally replicating lentiviral vector | Q24675343 |
| Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy | Q29615993 | ||
| Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
| Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells | Q31148079 | ||
| In vivo selection of protease cleavage sites from retrovirus display libraries | Q31992300 | ||
| Retroviral display and high throughput screening | Q33323460 | ||
| Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors | Q33839293 | ||
| Altered transcription of a defective measles virus genome derived from a diseased human brain | Q33928918 | ||
| Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. | Q34069549 | ||
| Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses | Q34439347 | ||
| Naive and memory B cells in T-cell-dependent and T-independent responses | Q34516552 | ||
| Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer | Q34516810 | ||
| Gene delivery by lentivirus vectors | Q34688367 | ||
| Targeting lentiviral vectors to specific cell types in vivo | Q34830842 | ||
| Targeting retroviral and lentiviral vectors. | Q35204394 | ||
| Retroviral retargeting by envelopes expressing an N-terminal binding domain. | Q35848344 | ||
| Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer | Q35859108 | ||
| Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells | Q36551563 | ||
| Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector | Q36586077 | ||
| Measles virus: cellular receptors, tropism and pathogenesis | Q36590422 | ||
| Mechanisms of killing by anti-CD20 monoclonal antibodies. | Q36927853 | ||
| The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate | Q37542714 | ||
| Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
| Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431 | Q37590584 | ||
| Role of the Bp35 cell surface polypeptide in human B-cell activation | Q37680761 | ||
| Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen | Q39605575 | ||
| Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses | Q39684160 | ||
| Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas | Q40171214 | ||
| Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions | Q40265687 | ||
| Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model | Q40377179 | ||
| A transient three-plasmid expression system for the production of high titer retroviral vectors | Q40393091 | ||
| CD20: a regulator of cell-cycle progression of B lymphocytes | Q40393831 | ||
| Dynamics of viral RNA synthesis during measles virus infection | Q40423254 | ||
| Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles. | Q40478194 | ||
| Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. | Q40478813 | ||
| Antibody-targeted cell fusion | Q40584431 | ||
| Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region | Q41258376 | ||
| Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes | Q42798184 | ||
| Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. | Q44120659 | ||
| Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes | Q44495832 | ||
| Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine | Q45399249 | ||
| An oncolytic measles virus engineered to enter cells through the CD20 antigen | Q45729228 | ||
| High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter | Q45732758 | ||
| IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes | Q45856716 | ||
| Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent | Q45859330 | ||
| Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection | Q46167187 | ||
| Epidermal growth factor receptor dimerization monitored in live cells | Q73405755 | ||
| Molecular events in the assembly of retrovirus particles | Q77443966 | ||
| Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors | Q78447760 | ||
| Rescue and propagation of fully retargeted oncolytic measles viruses | Q81348398 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1427-1436 | |
| P577 | publication date | 2008-06-24 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Targeted cell entry of lentiviral vectors | |
| P478 | volume | 16 |
| Q39851905 | (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery |
| Q30378994 | A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. |
| Q57839812 | A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors |
| Q58671442 | A measles virus-based vaccine candidate mediates protection against Zika virus in an allogenic mouse pregnancy model |
| Q38917869 | A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins |
| Q59356321 | A simple strategy for retargeting lentiviral vectors to desired cell types via a disulfide-bond-forming protein-peptide pair |
| Q33711477 | A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. |
| Q33659389 | AAV's anatomy: roadmap for optimizing vectors for translational success |
| Q36014053 | Advances in foamy virus vector technology and disease correction could speed the path to clinical application |
| Q37782256 | Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy |
| Q45323818 | Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles |
| Q41899254 | CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells |
| Q42254939 | CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes |
| Q60948710 | CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells |
| Q41877997 | Cell type specific gene delivery by lentiviral vectors: New options in immunotherapy |
| Q33557477 | Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule |
| Q33663063 | Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus |
| Q37340427 | Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction |
| Q39199726 | DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety |
| Q34757199 | DARPins: an efficient targeting domain for lentiviral vectors |
| Q41890251 | Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins |
| Q42541148 | Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer |
| Q42198008 | Efficient and graded gene expression in glia and neurons of primary cerebellar cultures transduced by lentiviral vectors. |
| Q38623827 | Engineered T cell therapies |
| Q37702226 | Enhanced T cell receptor gene therapy for cancer |
| Q37643999 | Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins. |
| Q36777139 | Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors |
| Q34214473 | Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein |
| Q35285887 | Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis. |
| Q45872567 | Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes |
| Q34223822 | Gammaretroviral vectors: biology, technology and application |
| Q36584648 | Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis |
| Q35191320 | High levels of SOX5 decrease proliferative capacity of human B cells, but permit plasmablast differentiation. |
| Q39794655 | High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus |
| Q91588177 | High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency |
| Q64084603 | Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors |
| Q40211579 | Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. |
| Q34539879 | Immunization delivered by lentiviral vectors for cancer and infectious diseases |
| Q33945680 | Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo |
| Q38968105 | Improved retroviral episome transfer of transcription factors enables sustained cell fate modification. |
| Q40562689 | In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice. |
| Q98575481 | In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges |
| Q104451347 | In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges |
| Q34586080 | Interplay between HIV entry and transportin-SR2 dependency |
| Q41661161 | Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response |
| Q37677792 | Lentiviral vectors for immune cells targeting |
| Q24629462 | Lentiviral vectors in gene therapy: their current status and future potential |
| Q34517833 | Library screening and receptor-directed targeting of gammaretroviral vectors |
| Q59358732 | Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model |
| Q37386888 | Measles virus glycoprotein complex assembly, receptor attachment, and cell entry |
| Q34447329 | Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies |
| Q39011184 | Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. |
| Q41869921 | Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells |
| Q36607409 | Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo |
| Q38865601 | Nipah virus fusion protein: Importance of the cytoplasmic tail for endosomal trafficking and bioactivity |
| Q39488698 | Non-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells |
| Q91068833 | Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells |
| Q81706195 | On target: new envelopes for lentiviral vectors |
| Q35189635 | Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection |
| Q33619238 | Paramyxovirus entry and targeted vectors for cancer therapy |
| Q92185218 | Peste des petits ruminants virus hemagglutinin (H) induces lysosomal degradation of host cyclophilin A to facilitate viral replication |
| Q34292273 | Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer |
| Q39884626 | Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity |
| Q39562844 | RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors |
| Q26742169 | Recent Advances in Lentiviral Vaccines for HIV-1 Infection |
| Q37678176 | Recent advances in lentiviral vector development and applications |
| Q36047074 | Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment |
| Q37909042 | Receptors and tropisms of envelope viruses |
| Q33711459 | Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. |
| Q39702309 | Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins |
| Q45367595 | Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM. |
| Q45875762 | Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types |
| Q35988675 | Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins |
| Q58382398 | Retroviral Pseudotypes - From Scientific Tools to Clinical Utility |
| Q37809064 | Retroviral Vectors for Gene Therapy |
| Q40120585 | Selection of an optimal promoter for gene transfer in normal B cells. |
| Q27318247 | Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells |
| Q42863043 | Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors |
| Q30583252 | Specific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptors |
| Q37358531 | Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13. |
| Q30358662 | Structural basis of efficient contagion: measles variations on a theme by parainfluenza viruses. |
| Q38825120 | Surface modification via strain-promoted click reaction facilitates targeted lentiviral transduction |
| Q58726929 | Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes |
| Q34487264 | Synthetic virology: engineering viruses for gene delivery |
| Q42531593 | Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes |
| Q35851724 | Targeted entry of enveloped viruses: measles and herpes simplex virus I. |
| Q35666025 | Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins |
| Q45876186 | Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins |
| Q38043924 | Targeting lentiviral vectors for cancer immunotherapy |
| Q36827199 | The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function |
| Q38118762 | Transfer and Expression of Small Interfering RNAs in Mammalian Cells Using Lentiviral Vectors |
| Q90444691 | Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing |
| Q36757162 | Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells. |
| Q57050793 | Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules |
Search more.